ChemicalBook > CAS DataBase List > XL-647
XL-647
XL-647
- CAS No.781613-23-8
- Chemical Name:XL-647
- CBNumber:CB82628532
- Molecular Formula:C24H25Cl2FN4O2
- Formula Weight:491.3853032
- MOL File:781613-23-8.mol
XL-647 Property
- Boiling point 567.9±50.0 °C(Predicted)
- Density 1.356
- storage temp. Store at -20°C
- solubility DMF: 10 mg/ml; DMSO: 10 mg/ml; Ethanol: 10 mg/ml
- form A solid
- pka 10.16±0.40(Predicted)
- color White to off-white
- FDA UNII F6XM2TN5A1
- NCI Drug Dictionary tesevatinib
-
Symbol(GHS)
- Signal wordDanger
- Hazard statements H314
- Precautionary statements P260-P280-P303+P361+P353-P301+P330+P331-P304+P340+P310-P305+P351+P338+P310
XL-647 Chemical Properties,Usage,Production
- Uses XL 647 is a potent and selective EGFR phosphorylation inhibitor and may be used in the treatment of patients suffering from lung cancer. Orally available, multi-target tyrosine kinase inhibitor.
- Definition ChEBI: Tesevatinib is a member of the class of quinazolines that is quinazoline substituted by (3,4-dichloro-2-fluorophenyl)amino, methoxy, and [(3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl]methoxy groups at positions 4, 6 and 7, respectively. It is a multi-target tyrosine kinase inhibitor of EGFR, ErbB2, KDR, Flt4 and EphB4 and exhibits anti-cancer properties. It has a role as an antineoplastic agent, an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor and an epidermal growth factor receptor antagonist. It is a member of quinazolines, an aromatic ether, a member of monofluorobenzenes, a dichlorobenzene, a secondary amino compound, a diether and a tertiary amino compound.
-
in vivo
Tesevatinib (XL-647) shows potent and long-lived inhibition of the WT EGFRin vivo. Tesevatinib (XL-647) substantially inhibits the growth of H1975 xenograft tumors and reduces both tumor EGFR signaling and tumor vessel density[1].
- IC 50 EGFR: 0.3 nM (IC50); ErbB2: 16 nM (IC50); KDR: 1.5 nM (IC50); Flt-4: 8.7 nM (IC50)
XL-647 Preparation Products And Raw materials
Raw materials
Preparation Products
Global(73)Suppliers
-
Supplier:
- Tel:+86-0371-86658258<br/>+8613203830695
- Email:sales@coreychem.com
- Country:China
- ProdList:29859
- Advantage:58
-
Supplier:
- Tel:+1-631-485-4226
- Email:inquiry@bocsci.com
- Country:United States
- ProdList:19552
- Advantage:58
-
Supplier:
- Tel:+1-2135480471<br/>+1-2135480471
- Email:sales@sarms4muscle.com
- Country:China
- ProdList:10473
- Advantage:58
-
Supplier:
- Tel:
- Email:support@targetmol.com
- Country:United States
- ProdList:38630
- Advantage:58
-
Supplier:
- Tel:+1-817863-6948<br/>+1-(817)863-6948
- Email:sales@aceschem.com
- Country:United States
- ProdList:19632
- Advantage:58
-
Supplier:
- Tel:+86-023-6139-8061<br/>+86-86-13650506873
- Email:sales@chemdad.com
- Country:China
- ProdList:39894
- Advantage:58
-
Supplier:
- Tel:571-89925085
- Email:sales@amadischem.com
- Country:China
- ProdList:131957
- Advantage:58
- Supplier: Jiangsu yize medical technology co. LTD
- Tel: 18962082606
- Email:3394205705@qq.com
- Country:China
- ProdList:1751
- Advantage:58
- Supplier: Jiangsu yize medical technology co. LTD
- Tel: 18962082606
- Email:3394205705@qq.com
- Country:China
- ProdList:9906
- Advantage:58
- Supplier: Shanghai Boyle Chemical Co., Ltd.
- Tel:
- Email:sales@boylechem.com
- Country:China
- ProdList:2922
- Advantage:55
781613-23-8, XL-647Related Search:
- AZD 3759 AG 1478 HYDROCHLORIDE OSI-420 Anlotinib EGF816 Tucatinib Neratinib Poziotinib (HM781-36B) CO-1686 Dacomitinib (PF299804) AZD-9291 TMC-207 N-[3-[4-[4-[(Cyclohexylmethylsulfonyl)amino]butyl]piperazin-1-yl]phenyl]acetamide RGB-286638 (free base) N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide Hcl BMS 777607 Fatostatin A Fatostatin A
- 抑制剂
- 标准品
- 细胞生物学试剂
- C24H25Cl2FN4O2
- 多靶点酪氨酸激酶抑制剂(XL-647)
- 化合物TESEVATINIB,10 MM DMSO 溶液
- N-(3,4-二氯-2-氟苯基)-6-甲氧基-7-(((3AR,5R,6AS)-2-甲基八氢环戊烷并[C]吡咯-5-基)甲氧基)喹唑啉-4-胺
- 化合物TESEVATINIB
- N-(3,4-二氯-2-氟苯基)-6-甲氧基-7-(((3AR,5R,6AS)-2-甲基八氢环戊戊二烯并[C]吡咯-5-基)甲氧基)喹唑啉-4-胺
- N-(3,4-二氯-2-氟苯基)-6-甲氧基-7-[[(3AALPHA,5BETA,6AALPHA)-八氢-2-甲基环戊并[C]吡咯-5-基]甲氧基]-4-喹唑啉胺
- 781613-23-8
- Tesevatinib, 10 mM in DMSO
- N-(3,4-Dichloro-2-fluorophenyl)-6-methoxy-7-(((3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine
- 4-Quinazolinamine, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-[[(3aα,5β,6aα)-octahydro-2-methylcyclopenta[c]pyrrol-5-yl]methoxy]-
- XL647 /EXEL-7647
- XL647,Tesevatinib,EXEL 7647,KD019,HER1,Ephrin Receptor,Inhibitor,VEGFR,KD 019,Vascular endothelial growth factor receptor,Epidermal growth factor receptor,EGFR,ErbB-1,XL 647,EXEL7647,inhibit
- Rel-N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine
- KD-019
- EXEL-7647;XL-647;XL 647
- N-(3,4-Dichloro-2-fluorophenyl)-6-methoxy-7-[[(3aalpha,5beta,6aalpha)-octahydro-2-methylcyclopenta[c]pyrrol-5-yl]methoxy]-4-quinazolinamine
- N-(3,4-dichloro-2-fluorophenyl)-6-Methoxy-7-(((3aR,6aS)-2-Methyloctahydrocyclopenta[c]pyrrol-5-yl)Methoxy)quinazolin-4-aMine
- XL-647
- Tesevatinib(XL647)
- Tesevatinib